Related Experiment Video
Updated: Dec 13, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Matrix Metalloproteinases Increase Because of Hypoperfusion in Obstructive Hypertrophic Cardiomyopathy
Xuanye Bi1, Chengzhi Yang1, Yunhu Song1
1State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Background:
Myocardial fibrosis (MF) is considered a result of microvascular dysfunction in patients with hypertrophic cardiomyopathy. Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs), capable of degrading collagen, directly participate in the development of MF. First we investigated the relationships among MF, microvascular rarefaction, and MMPs. Then we assessed the prognostic value of MF-related circulating biomarkers.
Methods:
Fifty-five obstructive hypertrophic cardiomyopathy (HOCM) patients were enrolled after surgical myectomy. Myocardial samples were performed with Masson's trichrome staining and immunohistochemical procedures for collagen volume fraction and microvascular density, respectively. Enzyme-linked immunosorbent assays were used to assess myocardial and plasma of MMP-2, MMP-9, and TIMP-1 and plasma C-terminal propeptide of procollagen type Ⅰ (PICP) and C-terminal telopeptide of type Ⅰ collagen (ICTP) levels. The composite cardiovascular endpoint consisted of new-onset atrial fibrillation, heart failure requiring hospitalization, and all-cause death.
Results:
In HOCM patients microvascular density was associated with the myocardial MMP-2/TIMP-1 ratio (r = -0.348, P = .009), whereas no correlation was found between collagen volume fraction and myocardial MMPs. During the 44-month follow-up 6 patients experienced a cardiovascular endpoint. The plasma PICP/ICTP ratio and MMP-2/TIMP-1 ratio were the 2 strongest prognostic makers. In multivariable analyses high PICP/ICTP and MMP-2/TIMP-1 ratios remained independent predictors of cardiovascular outcomes after adjusting for clinical confounders (hazard ratios, 12.683 [P = .021] and 17.037 [P = .027], respectively).
Conclusions:
In HOCM patients the myocardial MMP-2/TIMP-1 ratio was elevated because of microvascular rarefaction but may not be responsible for MF. High plasma PICP/ICTP and MMP-2/TIMP-1 ratios are independent predictors of adverse outcomes in HOCM patients.
Insights
In hypertrophic cardiomyopathy, high plasma ratios of PICP/ICTP and MMP-2/TIMP-1 predict adverse cardiovascular outcomes. These biomarkers indicate poor prognosis in patients with obstructive hypertrophic cardiomyopathy.
Area of Science:
- Cardiology
- Biomarkers
- Pathophysiology
Background:
- Myocardial fibrosis (MF) is linked to microvascular dysfunction in hypertrophic cardiomyopathy.
- Matrix metalloproteinases (MMPs) and tissue inhibitors (TIMPs) influence collagen degradation and MF development.
Purpose of the Study:
- Investigate relationships between MF, microvascular rarefaction, and MMPs.
- Assess prognostic value of MF-related circulating biomarkers in obstructive hypertrophic cardiomyopathy (HOCM).
Main Methods:
- Analyzed myocardial samples from 55 HOCM patients post-surgery for fibrosis and microvascular density.
- Measured myocardial and plasma levels of MMP-2, MMP-9, TIMP-1, PICP, and ICTP.
- Assessed composite cardiovascular endpoints over 44-month follow-up.
Main Results:
- Microvascular density correlated with myocardial MMP-2/TIMP-1 ratio (r = -0.348, P = .009).
- Plasma PICP/ICTP and MMP-2/TIMP-1 ratios were strong prognostic markers.
- High plasma PICP/ICTP and MMP-2/TIMP-1 ratios independently predicted adverse cardiovascular outcomes (HRs 12.683 and 17.037).
Conclusions:
- Myocardial MMP-2/TIMP-1 ratio elevation in HOCM may stem from microvascular rarefaction, not directly causing MF.
- Elevated plasma PICP/ICTP and MMP-2/TIMP-1 ratios are independent predictors of adverse outcomes in HOCM patients.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis I: Introduction
Role of Matrix Metalloproteases in Degradation of ECM
Heart Failure II: Pathophysiology
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification

